PLASMA SELENIUM LEVEL BEFORE DIAGNOSIS AND THE RISK OF PROSTATE CANCER DEVELOPMENT
- 1 December 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- p. 2034-2038
- https://doi.org/10.1097/00005392-200112000-00006
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Association Between alpha-Tocopherol, gamma-Tocopherol, Selenium, and Subsequent Prostate CancerJNCI Journal of the National Cancer Institute, 2000
- Study of Prediagnostic Selenium Level in Toenails and the Risk of Advanced Prostate CancerJNCI Journal of the National Cancer Institute, 1998
- Decreased incidence of prostate cancer with selenium supplementation: results of a double‐blind cancer prevention trialBritish Journal of Urology, 1998
- Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the SkinJAMA, 1996
- Levels of selenium in plasma and glutathione peroxidase in erythrocytes in patients with prostate cancer or benign hyperplasiaEuropean Journal Of Cancer Prevention, 1995
- Selenium in Forage Crops and Cancer Mortality in U.S. CountiesArchives of environmental health, 1991
- Serum Selenium and Subsequent Risk of Cancer Among Finnish Men and WomenJNCI Journal of the National Cancer Institute, 1990
- PREDIAGNOSTIC SERUM SELENIUM AND RISK OF CANCERThe Lancet, 1983
- Effect of Dietary Selenium on N-2 Fluorenyl-Acetamide (FAA)-Induced Cancer in Vitamin E Supplemented, Selenium Depleted RatsClinical Toxicology, 1972
- Protection against cocarcinogenesis by antioxidantsCellular and Molecular Life Sciences, 1966